+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Fracture Drug"

Teriparatide- Biosimilar Insight, 2022 - Product Thumbnail Image

Teriparatide- Biosimilar Insight, 2022

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Bone Fracture - Pipeline Review, H2 2019 - Product Thumbnail Image

Bone Fracture - Pipeline Review, H2 2019

  • Drug Pipelines
  • November 2019
  • 75 Pages
  • Global
From
  • 4 Results (Page 1 of 1)
Loading Indicator

The Fracture Drug market is a subset of the Musculoskeletal Disorders Drugs market, which focuses on treatments for conditions such as osteoporosis, arthritis, and other bone and joint diseases. Fracture Drugs are used to treat bone fractures, which can be caused by trauma, disease, or other medical conditions. These drugs are used to reduce pain, promote healing, and prevent further damage. Commonly used Fracture Drugs include bisphosphonates, calcitonin, and teriparatide. Bisphosphonates are used to reduce bone loss and increase bone density, while calcitonin is used to reduce pain and inflammation. Teriparatide is used to stimulate new bone growth. Some companies in the Fracture Drug market include Amgen, Eli Lilly, Merck, and Novartis. Show Less Read more